245 related articles for article (PubMed ID: 17868856)
1. Lymphocytic variant hypereosinophilic syndromes.
Roufosse F; Cogan E; Goldman M
Immunol Allergy Clin North Am; 2007 Aug; 27(3):389-413. PubMed ID: 17868856
[TBL] [Abstract][Full Text] [Related]
2. Hypereosinophilic syndromes.
Roufosse FE; Goldman M; Cogan E
Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
[TBL] [Abstract][Full Text] [Related]
3. Clinical overview of hypereosinophilic syndromes.
Sheikh J; Weller PF
Immunol Allergy Clin North Am; 2007 Aug; 27(3):333-55. PubMed ID: 17868853
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in pathogenesis and management of hypereosinophilic syndromes.
Roufosse F; Cogan E; Goldman M
Allergy; 2004 Jul; 59(7):673-89. PubMed ID: 15180753
[TBL] [Abstract][Full Text] [Related]
5. Hypereosinophilic syndrome and proliferative diseases.
Ionescu MA; Wang L; Janin A
Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
[TBL] [Abstract][Full Text] [Related]
6. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
Lee CH; Mamelak AJ; Vonderheid EC
Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
[TBL] [Abstract][Full Text] [Related]
7. The hypereosinophilic syndrome revisited.
Roufosse F; Cogan E; Goldman M
Annu Rev Med; 2003; 54():169-84. PubMed ID: 12525672
[TBL] [Abstract][Full Text] [Related]
8. Oral mucosa lesions in hypereosinophilic syndrome--an update.
Ionescu MA; Murata H; Janin A
Oral Dis; 2008 Mar; 14(2):115-22. PubMed ID: 18194138
[TBL] [Abstract][Full Text] [Related]
9. The hypereosinophilic syndromes: still more heterogeneity.
Gleich GJ; Leiferman KM
Curr Opin Immunol; 2005 Dec; 17(6):679-84. PubMed ID: 16214314
[TBL] [Abstract][Full Text] [Related]
10. Dermatologic manifestations of the hypereosinophilic syndromes.
Leiferman KM; Gleich GJ; Peters MS
Immunol Allergy Clin North Am; 2007 Aug; 27(3):415-41. PubMed ID: 17868857
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of chronic hypereosinophilia: new perspectives].
Prin L; Roumier AS
Therapie; 2001; 56(4):389-95. PubMed ID: 11677861
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular manifestations of hypereosinophilic syndromes.
Ogbogu PU; Rosing DR; Horne MK
Immunol Allergy Clin North Am; 2007 Aug; 27(3):457-75. PubMed ID: 17868859
[TBL] [Abstract][Full Text] [Related]
13. Hypereosinophilic syndromes.
Kahn JE; Blétry O; Guillevin L
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):863-82. PubMed ID: 19028368
[TBL] [Abstract][Full Text] [Related]
14. 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome.
Ravoet M; Sibille C; Roufosse F; Duvillier H; Sotiriou C; Schandené L; Martiat P; Goldman M; Willard-Gallo KE
Haematologica; 2005 Jun; 90(6):753-65. PubMed ID: 15951288
[TBL] [Abstract][Full Text] [Related]
15. Hypereosinophilic syndrome: an update.
Wilkins HJ; Crane MM; Copeland K; Williams WV
Am J Hematol; 2005 Oct; 80(2):148-57. PubMed ID: 16184589
[TBL] [Abstract][Full Text] [Related]
16. Advances in diagnosis and treatment of eosinophilia.
Sheikh J; Weller PF
Curr Opin Hematol; 2009 Jan; 16(1):3-8. PubMed ID: 19057198
[TBL] [Abstract][Full Text] [Related]
17. [Hypereosinophilia: what is important to the clinician?].
Bertrand E
Med Trop (Mars); 1998; 58(4 Suppl):512. PubMed ID: 10410377
[No Abstract] [Full Text] [Related]
18. [Hypereosinophilic syndrome].
Ishizuka T; Mori M
Ryoikibetsu Shokogun Shirizu; 2000; (31):558-61. PubMed ID: 11269162
[No Abstract] [Full Text] [Related]
19. [Practical approach to hypereosinophilia].
Roufosse F; Cogan E
Rev Med Brux; 2008 Sep; 29(4):400-8. PubMed ID: 18949995
[TBL] [Abstract][Full Text] [Related]
20. [Hypereosinophilic syndromes: pathogenic and therapeutic up-to-date].
Kahn JE; Grandpeix-Guyodo C; Ackermann F; Charles P; Legrand F; Blétry O
Rev Med Interne; 2010 Apr; 31(4):268-76. PubMed ID: 20303627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
